Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque

Cerebrovascular Diseases

Volumn 35, Issue 4, 2013, Pages 370-377

  Saito, Hisayasu ^a   Kuroda, Satoshi ^a   Hirata, Kenji ^a   Magota, Keiichi ^a   Shiga, Tohru ^a   Tamaki, Nagara ^a   Yoshida, Daisuke ^a   Terae, Satoshi ^a   Nakayama, Naoki ^a   Houkin, Kiyohiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carotid stenosis; FDG PET; Ischemic stroke; MRI; Vulnerable plaque

Indexed keywords

CD68 ANTIBODY; FLUORODEOXYGLUCOSE F 18; GELATINASE B; LYMPHOCYTE ANTIBODY; UNCLASSIFIED DRUG; CD68 ANTIGEN; EOSIN; HEMATOXYLIN; LIPID;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ATAXIC APHASIA; CALCIFICATION; HEMATOMA; HEMIPARESIS; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; VALIDITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RUPTURE, SPONTANEOUS; STROKE;

EID: 84876800415     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000348846     Document Type: Article

References (45)

1. European Carotid Surgery Trialists' Collaborative Group: MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-1243.
2. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-1428.
3. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D, MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004; 363: 1491-1502.
4. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-453.
5. Kwee RM, van Oostenbrugge RJ, Prins MH, Ter Berg JW, Franke CL, Korten AG, Meems BJ, van Engelshoven JM, Wildberger JE, Mess WH, Kooi ME: Symptomatic patients with mild and moderate carotid stenosis: Plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 2010; 41: 1389-1393.
6. Mono ML, Karameshev A, Slotboom J, Remonda L, Galimanis A, Jung S, Findling O, De Marchis GM, Luedi R, Kiefer C, Stuker C, Mattle HP, Schroth G, Arnold M, Nedeltchev K, El-Koussy M: Plaque characteristics of asymptomatic carotid stenosis and risk of stroke. Cerebrovasc Dis 2012; 34: 343-350.
7. Motegi H, Kuroda S, Nakayama N, Hirata K, Shiga T, Tamaki N: Fluorine-18-fluorodeoxyglucose positron emission tomography may predict the outcome in patients with asymptomatic mild stenosis of internal carotid artery Y case report. Neurol Med Chir (Tokyo) 2011; 51: 720-723.
8. Yoshida K, Sadamasa N, Narumi O, Chin M, Yamagata S, Miyamoto S: Symptomatic low-grade carotid stenosis with intraplaque hemorrhage and expansive arterial remodeling is associated with a high relapse rate refractory to medical treatment. Neurosurgery 2012; 70: 1143-1150; discussion 1150-1151.
9. Reiter M, Horvat R, Puchner S, Rinner W, Polterauer P, Lammer J, Minar E, Bucek RA: Plaque imaging of the internal carotid artery Y correlation of B-flow imaging with histopathology. AJNR Am J Neuroradiol 2007; 28: 122-126.
10. Kurosaki Y, Yoshida K, Endo H, Chin M, Yamagata S: Association between carotid atherosclerosis plaque with high signal intensity on T1-weighted imaging and subsequent ipsilateral ischemic events. Neurosurgery 2011; 68: 62-67.
11. Murphy RE, Moody AR, Morgan PS, Martel AL, Delay GS, Allder S, MacSweeney ST, Tennant WG, Gladman J, Lowe J, Hunt BJ: Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 2003; 107: 3053-3058.
12. Yoshimura S, Yamada K, Kawasaki M, Asano T, Kanematsu M, Takamatsu M, Hara A, Iwama T: High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke 2011; 42: 3132-3137.
13. Hishikawa T, Iihara K, Yamada N, Ishibashi-Ueda H, Miyamoto S: Assessment of necrotic core with intraplaque hemorrhage in atherosclerotic carotid artery plaque by MR imaging with 3D gradient-echo sequence in patients with high-grade stenosis. Clinical article. J Neurosurg 2010; 113: 890-896.
14. Howarth S, Li ZY, Trivedi RA, U-King-Im JM, Graves MJ, Kirkpatrick PJ, Gillard JH: Correlation of macrophage location and plaque stress distribution using USPIO-enhanced MRI in a patient with symptomatic severe carotid stenosis: A new insight into risk stratification. Br J Neurosurg 2007; 21: 396-398.
15. Metz S, Beer AJ, Settles M, Pelisek J, Botnar RM, Rummeny EJ, Heider P: Characterization of carotid artery plaques with USPIOenhanced MRI: Assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. Int J Cardiovasc Imaging 2011; 27: 901-912.
16. Watanabe Y, Nagayama M: MR plaque imaging of the carotid artery. Neuroradiology 2010; 52: 253-274.
17. Watanabe Y, Nagayama M, Suga T, Yoshida K, Yamagata S, Okumura A, Amoh Y, Nakashita S, Van Cauteren M, Dodo Y: Characterization of atherosclerotic plaque of carotid arteries with histopathological correlation: Vascular wall MR imaging vs. color Doppler ultrasonography (US). J Magn Reson Imaging 2008; 28: 478-485.
18. Yoshida K, Narumi O, Chin M, Inoue K, Tabuchi T, Oda K, Nagayama M, Egawa N, Hojo M, Goto Y, Watanabe Y, Yamagata S: Characterization of carotid atherosclerosis and detection of soft plaque with use of black-blood MR imaging. AJNR Am J Neuroradiol 2008; 29: 868-874.
19. Calcagno C, Cornily JC, Hyafil F, Rudd JH, Briley-Saebo KC, Mani V, Goldschlager G, Machac J, Fuster V, Fayad ZA: Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol 2008; 28: 1311-1317.
20. Hermus L, van Dam GM, Zeebregts CJ: Advanced carotid plaque imaging. Eur J Vasc Endovasc Surg 2010; 39: 125-133.
21. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnstrom P, Davenport AP, Lirkpatrick PL, Arch BN, Pickard JD, Weissberg PL: Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-2711.
22. Sheikine Y, Akram K: FDG-PET imaging of atherosclerosis: Do we know what we see? Atherosclerosis 2010; 211: 371-380.
23. Tahara N, Imaizumi T, Virmani R, Narula J: Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med 2009; 50: 331-334.
24. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T: Simvastatin attenuates plaque inflammation: Evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006; 48: 1825-1831.
25. Wu YW, Kao HL, Chen MF, Lee BC, Tseng WY, Jeng JS, Tzen KY, Yen RF, Huang PJ, Yang WS: Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med 2007; 48: 227-233.
26. Panin V, Kehren F, Michel C, Casey M: Fully 3-D PET reconstruction with system matrix derived from point source measurements. IEEE Trans Med Imaging 2006; 25: 907-921.
27. Stark H, Woods JW, Paul I, Hingorani R: An investigation of computerized tomography by direct Fourier inversion and optimum interpolation. IEEE Trans Biomed Eng 1981; 28: 496-505.
28. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238-1248.
29. Minoshima S, Koeppe RA, Frey KA, Kuhl DE: Anatomic standardization: Linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994; 35: 1528-1537.
30. Hokari M, Kuroda S, Yasuda H, Nakayama N, Abe S, Iwasaki Y, Saito H: Lumen morphology in mild-to-moderate internal carotid artery stenosis correlates with neurological symptoms. J Neuroimaging 2011; 21: 348-354.
31. Homburg PJ, Rozie S, van Gils MJ, van den Bouwhuijsen QJ, Niessen WJ, Dippel DW, van der Lugt A: Association between carotid artery plaque ulceration and plaque composition evaluated with multidetector CT angiography. Stroke 2011; 42: 367-372.
32. Redgrave JN, Lovett JK, Syed AB, Rothwell PM: Histological features of symptomatic carotid plaques in patients with impaired glucose tolerance and diabetes (Oxford plaque study). Cerebrovasc Dis 2008; 26: 79-86.
33. Bassiouny HS, Sakaguchi Y, Mikucki SA, McKinsey JF, Piano G, Gewertz BL, Glagov S: Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg 1997; 26: 585-594.
34. Maynor CH, Chatles HC, Herfkens RJ, Suddarth SA, Johnson GA: Chemical shift imaging of atherosclerosis at 7.0 Tesla. Invest Radiol 1989; 24: 52-60.
35. Serfaty JM, Chaabane L, Tabib A, Chevallier JM, Briguet A, Douek PC: Atherosclerotic plaques: Classification and characterization with T2-weighted high-spatial-resolution MR imaging Y an in vitro study. Radiology 2001; 219: 403-410.
36. Trivedi RA, U-King-Im J, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, Gillard JH: Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg 2004; 28: 207-213.
37. Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW, Ellington E, Ferguson MS, Hatsukami TS: Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002; 105: 181-185.
38. Kobayashi M, Ogasawara K, Inoue T, Saito H, Suga Y, Ogawa A: Endarterectomy for mild cervical carotid artery stenosis in patients with ischemic stroke events refractory to medical treatment. Neurol Med Chir (Tokyo) 2008; 48: 211-215.
39. Brooks WH, McClure RR, Jones MR, Coleman TL, Breathitt L: Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: A randomized trial in a community hospital. Neurosurgery 2004; 54: 318-324; discussion 324-325.
40. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A randomised trial. Lancet 2001; 357: 1729-1737.
41. Mantese VA, Timaran CH, Chiu D, Begg RJ, Brott TG, CREST Investigators: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): Stenting versus carotid endarterectomy for carotid disease. Stroke 2010; 41:S31-S34.
42. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X, EVA-3S Investigators: Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660-1671.
43. SPACE Collaborative Group, Ringleb PA, Allenberg J, Brückmann H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W: 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet 2006; 368: 1239-1247.
44. Yadav JS: Carotid stenting in high-risk patients: Design and rationale of the SAPPHIRE trial. Cleve Clin J Med 2004; 71:S45-S46.
45. Montorsi P, Caputi L, Galli S, Ciceri E, Ballerini G, Agrifoglio M, Ravagnani P, Trabattoni D, Pontone G, Fabbiocchi F, Loaldi A, Parati E, Andreini D, Veglia F, Bartorelli AL: Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection. J Am Coll Cardiol 2011; 58: 1656-1663.